SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Role of Public-Sector Research in the Discovery of Drugs and Vaccines
2 references·16 citing·47 second hop
The Role of Public-Sector Research in the Discovery of Drugs and Vaccines (2011)The Role of Public-Sector Research in the…The importance of new companies for drug discovery: origins of a decade of new drugs (2010)The importance of new compani…The price of innovation: new estimates of drug development costs (2003)The price of innovation: new …Big Pharma and monopoly capitalism: A long-term view (2023)Big Pharma and monopoly capit…Strategic Decision Making in the Digital Age: Expert Sentiment and Corporate Capital Allocation (2021)Strategic Decision Making in …Technological impact of biomedical research: The role of basicness and novelty (2020)Technological impact of biome…The effects of technology transfers and institutional factors on economic growth: evidence from Europe and Oceania (2019)The effects of technology tra…Public sector financial support for late stage discovery of new drugs in the United States: cohort study (2019)Public sector financial suppo…The impact of public R&D investments on patenting activity: technology transfer at the U.S. Environmental Protection Agency (2018)The impact of public R&D inve…Measuring the knowledge translation and convergence in pharmaceutical innovation by funding-science-technology-innovation linkages analysis (2018)Measuring the knowledge trans…Academic Medical Centers as Innovation Ecosystems: Evolution of Industry Partnership Models Beyond the Bayh–Dole Act (2018)Academic Medical Centers as I…The academic–industrial complex: navigating the translational and cultural divide (2017)The academic–industrial compl…The Roles Of Academia, Rare Diseases, And Repurposing In The Development Of The Most Transformative Drugs (2015)The Roles Of Academia, Rare D…Examining the Predictive Validity of NIH Peer Review Scores (2015)Examining the Predictive Vali…The fall and rise of pharmacology – (Re-)defining the discipline? (2013)The fall and rise of pharmaco…Translational research: the changing landscape of drug discovery (2012)Translational research: the c…Origins of Medical Innovation (2012)Origins of Medical InnovationUS academic drug discovery (2011)US academic drug discoveryThe Patent System and Climate Change (2011)The Patent System and Climate…Emergence of orphan drugs in the United States: a quantitative assessment of the first 25 years (2010)Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer (2011)The productivity crisis in pharmaceutical R&D (2011)Clinical benefit, price and approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000–2015 (2017)New “21st Century Cures” Legislation (2017)On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients (2020)Drug discovery in jeopardy (2006)Lessons from 60 years of pharmaceutical innovation (2009)Racing to define pharmaceutical R&D external innovation models (2014)Open for collaboration: an academic platform for drug discovery and development at SciLifeLab (2016)Ten Years of Medicinal Chemistry (2005–2014) in the Journal of Medicinal Chemistry: Country of Contributors, Topics, and Public–Private Partnerships (2016)How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)When fragments link: a bibliometric perspective on the development of fragment-based drug discovery (2018)A bibliometric measure of translational science (2020)Characterizing interdisciplinarity in drug research: A translational science perspective (2021)Regional advantage: culture and competition in Silicon Valley and Route 128 (1994)The New Argonauts. Regional Advantage in a Global Economy (2009)Big Pharma, little science? (2012)Orphan drug development: an economically viable strategy for biopharma R&D (2012)Asymmetric Growth and Institutions in an Interdependent World (2017)University Versus Corporate Patents: A Window On The Basicness Of Invention (1997)An analysis of the critical role of public science in innovation: the case of biotechnology (2000)A Study on Dynamic Patterns of Technology Convergence with IPC Co-Occurrence-Based Analysis: The Case of 3D Printing (2020)A novel approach to measuring science-technology linkage: From the perspective of knowledge network coupling (2021)Exploring science-technology linkages: A deep learning-empowered solution (2022)The Iron Cage Revisited: Institutional Isomorphism and Collective Rationality in Organizational Fields (1983)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment Equations (1991)The impact of energy technology innovations on cleaner energy supply and carbon footprints in Europe: A linear versus nonlinear approach (2020)Green innovations for sustainable development of China: Analysis based on the nested spatial panel models (2021)Does China's low-carbon city pilot policy improve energy efficiency? (2023)The entrepreneurial state: debunking public vs. private sector myths (2014)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)The Structure of Scientific Revolutions (1963)The Structure of Scientific Revolutions (1963)The dynamics of innovation: from National Systems and “Mode 2” to a Triple Helix of university–industry–government relations (2000)Does the recombination of distant scientific knowledge generate valuable inventions? An analysis of pharmaceutical patents (2023)Interdisciplinary research and technological impact: evidence from biomedicine (2023)The knowledge linkage between science and technology influences corporate technological innovation: Evidence from scientific publications and patents (2023)Efficient Capital Markets: A Review of Theory and Empirical Work (1970)A perspective on judgment and choice: Mapping bounded rationality. (2003)Giving Content to Investor Sentiment: The Role of Media in the Stock Market (2007)Corporate decline and turnarounds in times of digitalization (2022)Micro-foundations of digital innovation capability – A mixed method approach to develop and validate a multi-dimensional measurement instrument (2023)The impact of artificial intelligence on green transformation of manufacturing enterprises: evidence from China (2024)Can the pharmaceutical industry reduce attrition rates? (2004)Clinical development success rates for investigational drugs (2014)
this work references cited by second hop

References

  • 2003The price of innovation: new estimates of drug development costs4,264 cited
  • 2010The importance of new companies for drug discovery: origins of a decade of new drugs344 cited

Cited by

  • 2015The Roles Of Academia, Rare Diseases, And Repurposing In The Development Of The Most Transformative Drugs144 cited
  • 2011US academic drug discovery101 cited
  • 2019Public sector financial support for late stage discovery of new drugs in the United States: cohort study77 cited
  • 2018Measuring the knowledge translation and convergence in pharmaceutical innovation by funding-science-technology-innovation linkages analysis57 cited
  • 2019The effects of technology transfers and institutional factors on economic growth: evidence from Europe and Oceania56 cited
  • 2021Strategic Decision Making in the Digital Age: Expert Sentiment and Corporate Capital Allocation54 cited
  • 2020Technological impact of biomedical research: The role of basicness and novelty49 cited
  • 2012Translational research: the changing landscape of drug discovery46 cited
  • 2023Big Pharma and monopoly capitalism: A long-term view39 cited
  • 2013The fall and rise of pharmacology – (Re-)defining the discipline?36 cited
  • 2018The impact of public R&D investments on patenting activity: technology transfer at the U.S. Environmental Protection Agency26 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2018
Academic Medical Centers as Innovation Ecosystems: Evolution of Industry Partnership Models Beyond the Bayh–Dole Act
24 cited
  • 2015Examining the Predictive Validity of NIH Peer Review Scores24 cited
  • 2012Origins of Medical Innovation22 cited
  • 2011The Patent System and Climate Change20 cited
  • 2017The academic–industrial complex: navigating the translational and cultural divide16 cited